Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Young women with PCOS without additional risk factors may have normal heart function.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Polycystic ovary syndrome (PCOS) is more common in urban areas, possibly due to lifestyle and diet, and ignoring it can lead to serious health issues.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.